Yahoo
ASX - Delayed Quote AUD

Sigma Healthcare Limited (SIG.AX)

2.7300 +0.0100 (+0.37%)
At close: October 30 at 4:12:13 PM GMT+11
Chart Range Bar
Loading chart for SIG.AX
  • Previous Close 2.7200
  • Open 2.7200
  • Bid 2.7200 x --
  • Ask 2.7300 x --
  • Day's Range 2.7100 - 2.7600
  • 52 Week Range 2.4700 - 3.2000
  • Volume 14,972,799
  • Avg. Volume 18,186,212
  • Market Cap (intraday) 31.514B
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 45.50
  • EPS (TTM) 0.0600
  • Earnings Date Aug 27, 2026
  • Forward Dividend & Yield 0.04 (1.47%)
  • Ex-Dividend Date Sep 3, 2026
  • 1y Target Est 3.15

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.

sigmahealthcare.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

SIG.AX
5.76%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

SIG.AX
10.91%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

SIG.AX
347.87%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

SIG.AX
428.08%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

2.70
3.15 Average
2.7300 Current
3.75 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.54%

  • Return on Assets (ttm)

    7.21%

  • Return on Equity (ttm)

    14.69%

  • Revenue (ttm)

    10.83B

  • Net Income Avi to Common (ttm)

    709.18M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    131.12M

  • Total Debt/Equity (mrq)

    40.50%

  • Levered Free Cash Flow (ttm)

    390.57M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: